OnePlus seeks FDA approval for Sleep Apnea Detection on its watch and takes on Apple in the process
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions –– Reflects positive preliminary Phase 2 Safety ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
OnePlus Watch 3 owners in the US are missing out on vital health and fitness features
“The OnePlus Watch 3 did not receive official certification from the U.S. FDA on its ECS capabilities, the ECG Analyzer ...
Pharmabiz1d
Orchid Pharma's Alathur API facility successfully completes US FDA inspection
Orchid Pharma's Alathur API facility successfully completes US FDA inspection: Our Bureau, Mumbai Thursday, February 20, 2025, 11:30 Hrs [IST] Orchid Pharma Ltd., a vertically int ...
Orchid Pharma hits 5% upper circuit after USFDA inspection at TN facility
The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in ...
Orchid Pharma shares in focus as U.S. FDA completes facility inspection
Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosporins, a ...
Hosted on MSN2d
Imricor’s second-generation Vision-MR Ablation Catheter earns CE mark
Imricor’s second-generation Vision-MR Ablation Catheter has received CE mark certification under new, more-stringent, ...
Healio6d
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
BioSpace6d
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
FDA Grants Fast-Track Designation To Cannabis Withdrawal Syndrome Drug
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...